Evaluating the Risks of High Altitude Travel in Chronic Liver Disease Patients

High Altitude Medicine and Biology

Volumn 16, Issue 2, 2015, Pages 80-88

  Luks, Andrew M ^a   Swenson, Erik R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Altitude illness; Cirrhosis; Clinical hepatology; Hepatopulmonary syndrome; Hypoxia; Portopulmonary hypertension

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; IBUPROFEN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SILDENAFIL; TADALAFIL;

ALTITUDE; ALTITUDE DISEASE; CHRONIC LIVER DISEASE; CLINICAL EVALUATION; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; GRAFT RECIPIENT; HEADACHE; HEALTH CARE PLANNING; HEPATOPULMONARY SYNDROME; HIGH RISK PATIENT; HUMAN; HYPOXIA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; LUNG EDEMA; NEUROLOGIC DISEASE; NONHUMAN; PORTOPULMONARY HYPERTENSION; PRACTICE GUIDELINE; PREVENTION STUDY; PRIORITY JOURNAL; RESIDENTIAL AREA; REVIEW; RISK ASSESSMENT; RISK FACTOR; TRAVEL; ACCLIMATIZATION; ALTITUDE SICKNESS; COMPLICATION; LIVER DISEASE;

ACCLIMATIZATION; ALTITUDE; ALTITUDE SICKNESS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; RISK FACTORS; TRAVEL;

EID: 84931068227     PISSN: 15270297     EISSN: 15578682     Source Type: Journal    
DOI: 10.1089/ham.2014.1122     Document Type: Review

References (93)

1. Adak A, Maity C, Ghosh K, and Mondal KC. (2014). Alteration of predominant gastrointestinal flora and oxidative damage of large intestine under simulated hypobaric hypoxia. Z Gas-troenterol 52:180-186.
2. Adak A, Maity C, Ghosh K, Pati BR, and Mondal KC. (2013). Dynamics of predominant microbiota in the human gastrointestinal tract and change in luminal enzymes and immu-noglobulin profile during high-altitude adaptation. Folia Microbiol (Praha) 58:523-528.
3. Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, and Oelz O. (1991). Prevention of high-altitude pulmonary edema by ni-fedipine. N Engl J Med 325:1284-1289.
4. Bartsch P, Mairbaurl H, Maggiorini M, and Swenson ER. (2005). Physiological aspects of high-altitude pulmonary edema. J Appl Physiol 98:1101-1110.
5. Bartsch P, Mairbaurl H, Swenson ER, and Maggiorini M. (2003). High altitude pulmonary oedema. Swiss Med Wkly 133:377-384.
6. Bartsch P, and Swenson ER. (2013). Clinical practice: Acute high-altitude illnesses. N Engl J Med 368:2294-2302.
7. Bechstein WO. (2000). Neurotoxicity of calcineurin inhibitors: Impact and clinical management. Transpl Int 13:313-326.
8. Bennett WM, Aronoff GR, and Golper TA. (1987). Drug Prescribing in Renal Failure. American College of Physicians, Philadelphia, PA.
9. Berendsohn S. (1962). Hepatic function at high altitudes. Arch Intern Med 109:256-264.
10. Berman W, Jr., Wood SC, Yabek SM, Dillon T, Fripp RR, and Burstein R. (1987). Systemic oxygen transport in patients with congenital heart disease. Circulation 75:360-368.
11. Bogaard HJ, Grotjohan HP, Tjwa E, van den Berg FG, Postmus PE, van Nieuwkerk CM, and Vonk-Noordegraaf A. (2007). A 31-year-old man with hemoptysis at high altitude and abnormal hepatic biochemistry tests. Chest 132:1088-1092.
12. Burtscher M, Flatz M, and Faulhaber M. (2004). Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt Med Biol 5:335-340.
13. Copple BL, Bai S, Burgoon LD, and Moon JO. (2010a). Hypoxia-inducible factor-1alpha regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis. Liver Int 31:230-244.
14. Copple BL, Bai S, and Moon JO. (2010b). Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic Kupffer cells. Hepatol Res 40:530-539.
15. Copple BL, Bustamante JJ, Welch TP, Kim ND, and Moon JO. (2009). Hypoxia-inducible factor-dependent production of profibrotic mediators by hypoxic hepatocytes. Liver Int 29:1010-1021.
16. Cote TR, Stroup DF, Dwyer DM, Horan JM, and Peterson DE. (1993). Chronic obstructive pulmonary disease mortality. A role for altitude. Chest 103:1194-1197.
17. Cremona G, Higenbottam TW, Mayoral V, Alexander G, De-moncheaux E, Borland C, Roe P, and Jones GJ. (1995). Elevated exhaled nitric oxide in patients with hepato-pulmonary syndrome. Eur Respir J 8:1883-1885.
18. Daoud FS, Reeves JT, and Schaefer JW. (1972). Failure of hypoxic pulmonary vasoconstriction in patients with liver cirrhosis. J Clin Invest 51:1076-1080.
19. Dawson AM, De Groote J, Rosenthal WA, and Sherlock S. (1957). The effects of diamox ammonia metabolism in liver disease. Clin Sci (Lond) 16:413-420.
20. Dine CJ, and Kreider ME. (2008). Hypoxia altitude simulation test. Chest 133:1002-1005.
21. Dou K, Wang D, Zhao Q, Song Z, Yue S, Tao K, Chen S, He Y, and Ti Z. (2010). Liver transplantation in a patient with pulmonary hypertension at high altitude. Wilderness Environ Med 21:50-53.
22. Durmowicz AG. (2001). Pulmonary edema in 6 children with Down syndrome during travel to moderate altitudes. Pediatrics 108:443-447.
23. Ene MD, and Roberts CJ. (1987). Pharmacokinetics of nifedi-pine after oral administration in chronic liver disease. J Clin Pharmacol 27:1001-1004.
24. Finley DS, Lugo B, Ridgway J, Teng W, and Imagawa DK. (2005). Fatal variceal rupture after sildenafil use: Report of a case. Curr Surg 62:55-56.
25. Forgue ST, Phillips DL, Bedding AW, Payne CD, Jewell H, Patterson BE, Wrishko RE, and Mitchell MI. (2007). Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics. Br J Clin Pharmacol 63:24-35.
26. Friedland BR, and Maren TH. (1984). Carbonic anhydrase. Pharmacology of inhibitors and treatment of glaucoma. In: Pharmacology of the Eye. Handbook of Experimental Pharmacology. Sears ML, ed. Springer-Verlag, Berlin. pp. 279-309.
27. Fritz JS, Fallon MB, and Kawut SM. (2013). Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med 187:133-143.
28. Gertsch JH, Lipman GS, Holck PS, Merritt A, Mulcahy A, Fisher RS, Basnyat B, Allison E, Hanzelka K, Hazan A, Meyers Z, Odegaard J, Pook B, Thompson M, Slomovic B, Wahlberg H, Wilshaw V, Weiss EA, and Zafren K. (2010). Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: The Headache Evaluation at Altitude Trial (HEAT). Wilderness Environ Med 21:236-243.
29. Gonzalez-Casas R, Jones EA, and Moreno-Otero R. (2009). Spectrum of anemia associated with chronic liver disease. World J Gastroenterol 15:4653-4658.
30. Hackett PH, Creagh CE, Grover RF, Honigman B, Houston CS, Reeves JT, Sophocles AM, and Van Hardenbroek M. (1980). High-altitude pulmonary edema in persons without the right pulmonary artery. N Engl J Med 302:1070-1073.
31. Hackett PH, and Roach RC. (2001). High-altitude illness. N Engl J Med 345:107-114.
32. Hackett PH, and Roach RC. (2004). High altitude cerebral edema. High Alt Med Biol 5:136-146.
33. Hackett PH, Roach RC, Schoene RB, Harrison GL, and Mills WJ, Jr. (1988a). Abnormal control of ventilation in high-altitude pulmonary edema. J Appl Physiol 64:1268-1272.
34. Hackett PH, Roach RC, Wood RA, Foutch RG, Meehan RT, Rennie D, and Mills WJ, Jr. (1988b). Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 59:950-954.
35. Harinck E, Hutter PA, Hoorntje TM, Simons M, Benatar AA, Fischer JC, de Bruijn D, and Meijboom EJ. (1996). Air travel and adults with cyanotic congenital heart disease. Circulation 93:272-276.
36. Harris NS, Wenzel RP, and Thomas SH. (2003). High altitude headache: Efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J Emerg Med 24:383-387.
37. Hu HJ, Fan DF, Lv Y, Zhang Y, Yang C, Zhao L, Zhao RG, and Pan XW. (2013). Effects of simulated heliox diving at high altitudes on blood cells, liver functions and renal functions. Undersea Hyperb Med 40:329-337.
38. Jin S, Chen Z, Lunan Y, Zeng Y, Wen T, Li B, Zhao J, Wang W, Xu M, and Yang J. (2009). Can liver transplantation achieve similar effects at high altitudes compared with plains: Case report. Transpant Proc 41:2003-2005.
39. Jurgens G, Christensen HR, Brosen K, Sonne J, Loft S, and Olsen NV. (2002). Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans. Clin Pharmacol Ther 71:214-220.
40. Kalson NS, Hext F, Davies AJ, Chan CW, Wright AD, Imray CH, and Birmingham Medical Research Expeditionary S. (2010). Do changes in gastrointestinal blood flow explain high-altitude anorexia? Eur J Clin Invest 40:735-741.
41. Karinen HM, Peltonen JE, Kahonen M, and Tikkanen HO. (2010). Prediction of acute mountain sickness by monitoring arterial oxygen saturation during ascent. High Alt Med Biol 11:325-332.
42. Kleinbloesem CH, van Harten J, Wilson JP, Danhof M, van Brummelen P, and Breimer DD. (1986). Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration. Clin Pharmacol Ther 40:21-28.
43. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, and Wiesner RH. (2006). Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology 44:1502-1510.
44. Larsen JA, Krarup N, and Munck A. (1976). Liver hemody-namics and liver function in cats during graded hypoxic hypoxemia. Acta Physiol Scand 98:257-262.
45. Levine BD, Yoshimura K, Kobayashi T, Fukushima M, Shi-bamoto T, and Ueda G. (1989). Dexamethasone in the treatment of acute mountain sickness. N Engl J Med 321: 1707-1713.
46. Lipman GS, Kanaan NC, Holck PS, Constance BB, and Gertsch JH. (2012). Ibuprofen prevents altitude illness: A randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med 59: 484-490.
47. Luks AM. (2009a). Can patients with pulmonary hypertension travel to high altitude? High Alt Med Biol 10:215-219.
48. Luks AM. (2009b). Do lung disease patients need supplemental oxygen at high altitude? High Alt Med Biol 10:321-327.
49. Luks AM. (2009c). Should travelers with hypertension adjust their medications when traveling to high altitude? High Alt Med Biol 10:11-15.
50. Luks AM, Johnson RJ, and Swenson ER. (2008). Chronic kidney disease at high altitude. J Am Soc Nephrol 19:2262-2271.
51. Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, Schoene RB, Zafren K, and Hackett PH. (2014). Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update. Wilderness Environ Med 25:S4-S14.
52. Luks AM, and Swenson ER. (2008). Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness. Chest 133:744-755.
53. Luks AM, and Swenson ER. (2011). Pulse oximetry at high altitude. High Alt Med Biol 12:109-119.
54. Maggiorini M. (2006). High altitude-induced pulmonary oedema. Cardiovasc Res 72:41-50.
55. Moore LG, Harrison GL, McCullough RE, McCullough RG, Micco AJ, Tucker A, Weil JV, and Reeves JT. (1986). Low acute hypoxic ventilatory response and hypoxic depression in acute altitude sickness. J Appl Physiol 60:1407-1412.
56. Moore LG, Rohr AL, Maisenbach JK, and Reeves JT. (1982). Emphysema mortality is increased in Colorado residents at high altitude. Am Rev Respir Dis 126:225-228.
57. Muirhead GJ, Wilner K, Colburn W, Haug-Pihale G, and Rouviex B. (2002). The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil. Br J Clin Pharmacol 53:21S-30S.
58. Naeije R, De Backer D, Vachiery JL, and De Vuyst P. (1996). High-altitude pulmonary edema with primary pulmonary hypertension. Chest 110:286-289.
59. Nangaku M. (2006). Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol 17:17-25.
60. Noble JS, and Davidson JA. (1999). Cor pulmonale presenting in a patient with congenital kyphoscoliosis following intercontinental air travel. Anaesthesia. 54: 361-3.
61. Novo E, Cannito S, Paternostro C, Bocca C, Miglietta A, and Parola M. (2014). Cellular and molecular mechanisms in liver fibrogenesis. Arch Biochem Biophys 548:20-37.
62. O'Connor T, Dubowitz G, and Bickler PE. (2004). Pulse oxi-metry in the diagnosis of acute mountain sickness. High Alt Med Biol 5:341-348.
63. Ou LC, Faulkner C, Tam V, and Leiter JC. (2013). Liver function in rats acclimatized to a simulated altitude of 5500m. High Alt Med Biol 14:375-382.
64. Parkkila S. (2000). Roles of carbonic anhydrases in the alimentary tract. EXS 462-474.
65. Pastor CM. (2000). Hepatic and splanchnic oxygen consumption during acute hypoxemic hypoxia in anesthetized pigs. Crit Care Med 28:765-773.
66. Pirenne J, Van Gelder F, Kharkevitch T, Nevens F, Verslype C, Peetermans WE, Kitade H, Vanhees L, Devos Y, Hauser M, Hamoir E, Noizat-Pirenne F, and Pirotte B. (2004). Tolerance of liver transplant patients to strenuous physical activity in high-altitude. Am J Transplant 4:554-560.
67. Ramsoe K, Jarnum S, Preisig R, Tauber J, Tygstrup N, and Westergaard H. (1970). Liver function and blood flow at high altitude. J Appl Physiol 28:725-727.
68. Regev A, Yeshurun M, Rodriguez M, Sagie A, Neff GW, Molina EG, and Schiff ER. (2001). Transient hepatopulmonary syndrome in a patient with acute hepatitis A. J Viral Hepat 8: 83-86.
69. Rios B, Driscoll DJ, and McNamara DG. (1985). High-altitude pulmonary edema with absent right pulmonary artery. Pediatrics 75:314-317.
70. Roach RC, Greene ER, Schoene RB, and Hackett PH. (1998). Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med 69:1182-1185.
71. Roach RC, Houston CS, Honigman B, Nicholas RA, Yaron M, Grissom CK, Alexander JK, and Hultgren HN. (1995). How well do older persons tolerate moderate altitude? West J Med 162:32-36.
72. Rodriguez-Roisin R, and Krowka MJ. (2008). Hepatopulmonary syndrome-A liver-induced lung vascular disorder. N Engl J Med 358:2378-2387.
73. Rodriguez-Roisin R, Krowka MJ, Herve P, and Fallon MB. (2004). Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 24:861-880.
74. Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, and Bosch J. (1987). Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 135:1085-1092.
75. Rosmorduc O, and Housset C. (2010). Hypoxia: A link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease. Semin Liver Dis 30:258-270.
76. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, and Muller C. (2002). Hepatopulmonary syndrome: Prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 51:853-859.
77. Seifalian AM, El-Desoky H, Delpy DT, and Davidson BR. (2001). Effect of graded hypoxia on the rat hepatic tissue oxygenation and energy metabolism monitored by near-infrared and 31P nuclear magnetic resonance spectroscopy. FASEB J 15:2642-2648.
78. Shoji K, Tanaka T, and Nangaku M. (2014). Role of hypoxia in progressive chronic kidney disease and implications for therapy. Curr Opin Nephrol Hypertens 23:161-168.
79. Stanley NN, Kelsen SG, and Cherniack NS. (1976). Effect of liver failure on the ventilatory response to hypoxia in man and the goat. Clin Sci Mol Med 50:25-35.
80. Streit M, Goggelmann C, Dehnert C, Burhenne J, Riedel KD, Menold E, Mikus G, Bartsch P, and Haefeli WE. (2005). Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m). Eur J Clin Pharmacol 61:39-46.
81. Swenson ER, Maggiorini M, Mongovin S, Gibbs JS, Greve I, Mairbaurl H, and Bartsch P. (2002). Pathogenesis of high-altitude pulmonary edema: Inflammation is not an etiologic factor. JAMA 287:2228-2235.
82. Tabbara KF, Al-Faisal Z, and Al-Rashed W. (1998). Interaction between acetazolamine and cyclosporine. Arch Ophthalmol 116:832-833.
83. Tashkin DP, Goldstein PJ, and Simmons DH. (1972). Hepatic lactate uptake during decreased liver perfusion and hypose-mia. Am J Physiol 223:968-974.
84. Teuber G, Teupe C, Dietrich CF, Caspary WF, Buhl R, and Zeuzem S. (2002). Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis. Eur J Intern Med 13: 311-318.
85. Toff NJ. (1993). Hazards of air travel for the obese: Miss Pickwick and the Boeing 747. J R Coll Physicians Lond 27:375-376.
86. Torrington KG. (1989). Recurrent high-altitude illness associated with right pulmonary artery occlusion from granuloma-tous mediastinitis. Chest 96:1422-1424.
87. Vajro P, De Vincenzo A, Roussett A, and Bernard O. (1995). Life-threatening esophageal variceal bleeding after air transport to a liver transplantation center in a child with extra-hepatic biliary atresia. J Pediatr Gastroenterol Nutr 20: 479-480.
88. Valley MA, Trotter JF, Thomas D, Ginde AA, Lownenstein SR, and Honigman B. (2014). The relationship between hepato-pulmonary syndrome and altitude. Can J Gastroenterol He-patol 28:140-142.
89. Waisman Y, Klein BL, Rachmel A, Garty BZ, and Nitzan M. (1991). In-flight esophageal variceal bleeding en route for liver transplantation: A case report and review of the literature. Pediatr Emerg Care 7:157-159.
90. Wang YW, Lin HC, Yang YY, Hou MC, and Lee SD. (2006). Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension. J Gastroenterol 41:593-597.
91. Winkelmayer WC, Liu J, and Brookhart MA. (2009). Altitude and all-cause mortality in incident dialysis patients. JAMA 301:508-512.
92. Yang W, Hafez T, Thompson CS, Mikhailidis DP, Davidson BR, Winslet MC, and Seifalian AM. (2003). The effect of graded systemic hypoxaemia on hepatic tissue oxygenation. Adv Exp Med Biol 540:317-323.
93. Zhou QQ, Yang DZ, Luo YJ, Li SZ, Liu FY, and Wang GS. (2011). Over-starvation aggravates intestinal injury and promotes bacterial and endotoxin translocation under high-altitude hypoxic environment. World J Gastroenterol 17:1584-1593.